Clinical Trial Update: Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a nanocrystalline megestrol acetate formulation aiming to improve appetite and weight in treatment-naive patients with metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Nanocrystalline Megestrol Acetate (megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Metastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity, Untreated With Systemic Therapy | Phase 3 | Status: NOT_YET_RECRUITING